Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines

The Oral Vaccine Successfully Produced Antibodies in a Preclinical Study After a Single Dose NEW YORK, March 19, 2021 /PRNewswire/ — Good candidate for protection against COVID variants due to triple antigen targeting  Implications for potential ease of widescale distribution and administration anytime, anywhere for oral COVID-19 vaccine  Efficacy following a single oral dose administration […]

Join our mailing list

Skip to content